Women’s Health
R-Biopharm Australia’s Women’s Health diagnostics portfolio provides advanced molecular diagnostic solutions for the assessment of vaginal microbiota and the detection of pathogens associated with vaginitis and vaginosis. Using multiplex PCR technology, our assays enable clinical laboratories to accurately identify bacterial, fungal and parasitic targets while providing valuable insight into the balance of the vaginal microbiome. This comprehensive approach supports informed clinical decision-making and more personalised patient management.
Understanding the Vaginal Microbiome
A healthy vaginal microbiome plays an important role in maintaining reproductive health and protecting against infection. Changes in the balance of beneficial and pathogenic microorganisms can contribute to conditions such as bacterial vaginosis, vulvovaginal candidiasis and other vaginal infections. R-Biopharm Australia’s multiplex PCR solutions provide comprehensive analysis of vaginal microbiota, enabling clinical laboratories to assess microbial balance while accurately detecting clinically significant pathogens from a single sample. This detailed molecular insight supports more confident diagnosis and appropriate patient management in women’s health diagnostics.
Women’s Health Product Portfolio
BV & Thrush
Panels for determining the bacterial balance between normal and anaerobic flora, detection of the most common Candida species, and detection of Trichomonas vaginalis.
Bacteria
- Atopobium vaginae
- Gardnerella vaginalis
- Lactobacillus crispatus
- Lactobacillus iners
Fungi
- Candida albicans
- Candida parapsilosis
- Nakaseomyces glabratus (formerly Candida glabrata)
- Pichia kudriavzevii (formerly Candida krusei)
Parasites
- Trichomonas vaginalis
Ordering Information
| Ref | Description | Pack Size | Tests |
|---|---|---|---|
| 27117S | RIDA®Plex Vaginitis and Vaginosis 8 well Step 1 | 12 x 8-well Strips | 96 |
| 27117P | RIDA®Plex Vaginitis and Vaginosis 8 well Step 2 | 12 x 384-well Plates | 288 |
| 40241 | RIDA®Plex S DNA Cassette | 10 Cassettes | – |
| 91021 | RIDA®Plex Positive Control STIs and Herpes | 10 x 2mL Tubes | – |
Bacteria
- Atopobium vaginae
- Gardnerella vaginalis
- Lactobacillus crispatus
- Lactobacillus gasserii
- Lactobacillus iners
- Lactobacillus jensenii
- Lactobacillus johnsonii
Fungi
- Candida albicans
- Candida tropicalis
- Candida parapsilosis
- Nakaseomyces glabratus (formerly Candida glabrata)
- Pichia kudriavzevii (formerly Candida krusei)
Parasites
- Trichomonas vaginalis
Ordering Information
| Ref | Description | Pack Size | Tests |
|---|---|---|---|
| 87124S | RIDA®Plex Vaginitis and Vaginosis 12 well Step 1 | 12 x 8-well Strips | 96 |
| 87124P | RIDA®Plex Vaginitis and Vaginosis 12 well Step 2 | 12 x 384-well Plates | 288-384^ |
| 40231 | RIDA®Plex L DNA Cassette* | 10 Cassettes | – |
| 40631 | RIDA®Plex S DNA Reservoir** | 4 Reservoirs | – |
| 40621 | RIDA®Plex M DNA Reservoir** | 4 Reservoirs | – |
| 40611 | RIDA®Plex L DNA Reservoir** | 4 Reservoirs | – |
| 91021 | RIDA®Plex Positive Control STIs and Herpes | 10 x 2mL Tubes | – |
^ Step 2 plates allow for up to 288 tests on RIDA®Xplore, up to 384 tests on RIDA®Jump.
* Reagent Cassettes are for use with the RIDA®Xplore.
** Reagent Reservoirs are for use with the RIDA®Jump.
Comprehensive Women’s Health Diagnostic Solutions
Our Women’s Health portfolio provides comprehensive molecular diagnostics for assessing vaginal microbiota and detecting pathogens associated with vaginitis and vaginosis. Designed for clinical laboratories, our multiplex PCR solutions deliver detailed insight into microbial balance while identifying clinically significant bacterial, fungal and parasitic organisms from a single sample. Supported by local expertise, R-Biopharm Australia helps laboratories deliver accurate women’s health diagnostics with confidence.
A Deep Dive Into Multiplex Tandem PCR
Explore Our Technology
Our Women’s Health diagnostic solutions are supported by advanced molecular testing platforms designed to deliver reliable performance across a range of clinical applications. From automated extraction and multiplex PCR technologies to integrated workflows such as RIDA®Xplore Alliance and RIDA®Jump Alliance, our solutions help laboratories efficiently perform comprehensive women’s health testing with confidence. By combining innovative technology with robust assay performance, R-Biopharm Australia enables laboratories across Australia to achieve accurate, consistent and high-quality molecular diagnostic results.
RIDA®Plex IVD panels are intended for in vitro diagnostics use by authorised clinical testing laboratories in Australia, New Zealand, Great Britain, and the European Economic Area, and are included on the Australian Register of Therapeutic Goods (ARTG), the MHRA database (REF: 10541) and compliant with the European IVD Directive 98/79/EC. In the USA: For Research Use Only (RUO). For Research Use Only (RUO), not for use In diagnostic procedures. RIDA®Plex RUO panels are for Research Use Only in any jurisdiction.
